Fulminant Hepatic Failure Secondary to Adenovirus Following Fludarabine-Based Chemotherapy for Non-Hodgkin's Lymphoma

References

• Hale G A, Heslop H E, Krance R A, Brenner M A, Jayawardene D, Srivastava D K, Patrick C C. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplantation 1999; 23: 277–82
   PubMed Web of Science ®Google Scholar
• Michaels M G, Green M, Wald E R, Starzl T E. Adenovirus infection in pediatric liver transplant recipients. Journal of Infectious Diseases 1992; 165: 170–4
   PubMed Web of Science ®Google Scholar
• Bertheau P, Parquet N, Ferchal F, Gluckman E, Brocheriou C. Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation 1996; 17: 295–8
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Collingham K E, Fegan C D, Milligan D W. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplantation 1999; 23: 1209–11
   PubMed Web of Science ®Google Scholar
• Charles A K, Caul E O, Porter H J, Oakhill A. Fatal adenovirus 32 infection in a bone marrow transplant recipient. Journal of Clinical Pathology 1995; 48: 779–81
   PubMed Web of Science ®Google Scholar
• Dombrowski F, Eis-Hubinger A M, Ackermann T, Blumel J, Spengler U, Pfeifer U. Adenovirus-induced liver necrosis in a case of AIDS. Virchows Archiv 1997; 431: 469–72
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, Lister T A, Bloomfield C D. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Journal of Clinical Oncology 1999; 17: 3835–49
   PubMed Web of Science ®Google Scholar
• Hams N L, Jaffe E S, Stein H, Banks P M, Chan J K, Cleary M L, Delsol G, De Wolf-Peeters C, Falini B, Gatter K C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]. Blood 1994; 84: 1361–92
   PubMed Web of Science ®Google Scholar
• Lacaille F, Fournet J C, Blanche S. Clinical utility of liver biopsy in children with acquired immunodeficiency syndrome. Pediatric Infectious Disease Journal 1999; 18: 143–7
   PubMed Web of Science ®Google Scholar
• Shields A F, Hackman R C, Fife K H, Corey L, Meyers J D. Adenovirus infections in patients undergoing bone-marrow transplantation. New England Journal of Medicine 1985; 312: 529–33
   PubMed Web of Science ®Google Scholar
• Flomenberg P, Babbitt J, Drobyski W R, Ash R C, Carrigan D R, Sedmak G V, McAuliffe T, Camitta B, Horowitz M M, Bunin N, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. Journal of Infectious Diseases 1994; 169: 775–81
   PubMed Web of Science ®Google Scholar
• Echavarria M S, Ray S C, Ambinder R, Dumler J S, Charache P. PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease. Journal of Clinical Microbiology 1999; 37: 686–9
   PubMed Web of Science ®Google Scholar
• Ghez D, Oksenhendler E, Scieux C, Lassoued K. Haemorrhagic cystitis associated with adenovirus in a patient with AIDS treated for a non-Hodgkin's lymphoma. American Journal of Hematology 2000; 63: 32–4
   PubMed Web of Science ®Google Scholar
• Van Z, Nguyen S, Poles M, Melamed J, Scholes J V. Adenovirus colitis in human immunodeficiency virus infection: an underdiagnosed entity. American Journal of Surgical Pathology 1998; 22: 1101–6
   PubMed Web of Science ®Google Scholar
• Maddox A, Francis N, Moss J, Blanshard C, Gazzard B. Adenovirus infection of the large bowel in HIV positive patients. Journal of Clinical Pathology 1992; 45: 684–8
   PubMed Web of Science ®Google Scholar
• Janoff E N, Orenstein J M, Manischewitz J F, Smith P D. Adenovirus colitis in the acquired immunodeficiency syndrome. Gastroenterology 1991; 100: 976–9
   PubMed Web of Science ®Google Scholar
• Green W R, Greaves W L, Frederick W R, Taddesse-Heath L. Renal infection due to adenovirus in a patient with human immunodeficiency virus infection. Clinical Infectious Diseases 1994; 18: 989–91
   PubMed Web of Science ®Google Scholar
• Shintaku M, Nasu K, Ito M. Necrotizing tubulo-interstitial nephritis induced by adenovirus in an AIDS patient. Histopathology 1993; 23: 588–90
   PubMed Web of Science ®Google Scholar
• Puitilo D T, White R, Filipovich A, Kersey J, Zelkowitz L. Fulminant liver failure induced by adenovirus after bone marrow transplantation [letter]. New England Journal of Medicine 1985; 312: 1707–8
   Web of Science ®Google Scholar
• Hierholzer J C. Adenoviruses in the immunocompromised host. Clinical Microbiology Reviews 1992; 5: 262–74
   PubMed Web of Science ®Google Scholar
• Cames B, Rahier J, Burtomboy G, de Ville de Goyet J, Reding R, Lamy M, Otte J B, Sokal E M. Acute adenovirus hepatitis in liver transplant recipients. Journal of Pediatrics 1992; 120: 33–7
   PubMed Web of Science ®Google Scholar
• Dummer S, Kusne S. Liver transplantation and related infections. Seminars in Respiratory Infections 1993; 8: 191–8
   PubMedGoogle Scholar
• Koneru B, Jaffe R, Esquivel C O, Kunz R, Todo S, Iwatsuki S, Starzl T E. Adenoviral infections in pediatric liver transplant recipients. Jama 1987; 258: 489–92
   PubMed Web of Science ®Google Scholar
• Murphy G F, Wood D P, Jr., McRoberts J W, Henslee-Downey P J. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. Journal of Urology 1993; 149: 565–6
   PubMed Web of Science ®Google Scholar
• Cassano W F. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation 1991; 7: 247–8
   PubMed Web of Science ®Google Scholar
• Hromas R, Clark C, Blanke C, Tricot G, Cornetta K, Hedderman A, Broun E R. Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation [letter; comment]. Bone Marrow Transplantation 1994; 14: 663–4
   PubMed Web of Science ®Google Scholar
• Liles W C, Cushing H, Holt S, Bryan C, Hackman R C. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin [see comments]. Bone Marrow Transplantation 1993; 12: 409–12
   PubMed Web of Science ®Google Scholar
• Kitabayashi A, Hirokawa M, Kuroki J, Nishinari T, Niitsu H, Miura A B. Successful vidarabine therapy for adenovirus type 11-associated acute hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation 1994; 14: 853–4
   PubMed Web of Science ®Google Scholar
• Chen F E, Liang R H, Lo J Y, Yuen K Y, Chan T K, Peiris M. Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir. Bone Marrow Transplantation 1997; 20: 997–9
   PubMed Web of Science ®Google Scholar
• Hedderwick S A, Greenson J K, McGaughy V R, Clark M M. Adenovirus cholecystitis in a patient with AIDS. Clinical Infectious Diseases 1998; 26: 997–9
   PubMed Web of Science ®Google Scholar
• Saad R S, Demetris A J, Lee R G, Kusne S, Randhawa P S. Adenovirus hepatitis in the adult allograft liver. Transplantation 1997; 64: 1483–5
   PubMed Web of Science ®Google Scholar
• De Clercq E. New acquisitions in the chemotherapy of viral infections. Verhandelingen-Koninklijke Academic voor Geneeskunde van Belgie 1990; 52: 69–99
   PubMedGoogle Scholar
• Dagan R, Schwartz R H, Insel R A, Menegus M A. Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody. Pediatric Infectious Disease 1984; 3: 246–51
   PubMedGoogle Scholar
• Hromas R, Cornetta K, Srour E, Blanke C, Broun E R. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation [letter]. Blood 1994; 84: 1689–90
   PubMed Web of Science ®Google Scholar
• Rooney C M, Smith C A, Ng C Y, Loftin S, Li C, Krance R A, Brenner M K, Heslop H E. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995; 345: 9–13
   PubMed Web of Science ®Google Scholar
• Rooney C M, Heslop H E, Brenner M K. EBV specific CTL: a model for immune therapy. Vox Sanguinis 1998; 74: 497–8
   PubMed Web of Science ®Google Scholar
• Heslop H E, Ng C Y, Li C, Smith C A, Loftin S K, Krance R A, Brenner M K, Rooney C M. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Medicine 1996; 2: 551–5
   PubMed Web of Science ®Google Scholar
• Walter E A, Greenberg P D, Gilbert M I, Finch R J, Watanabe K S, Thomas E D, Riddell S R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor [see comments]. New England Journal of Medicine 1995; 333: 1038–44
   PubMed Web of Science ®Google Scholar